INTERNATIONAL PATENT: GUARDANT HEALTH, INC. FILES APPLICATION FOR "TUMOR FRACTION (TF) IS ASSOCIATED WITH REAL-WORLD PROGRESSION-FREE SURVIVAL (RWPFS) IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY (CHEMO)"

GENEVA, March 11 -- GUARDANT HEALTH, INC. (3100 Hanover StreetPalo Alto, California 94304) filed a patent application (PCT/US2025/043397) for "TUMOR FRACTION (TF) IS ASSOCIATED WITH REAL-WORLD PROGRESSION-FREE SURVIVAL (RWPFS) IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY (CHEMO)" on Aug 25, 2025. With publication no. WO/2026/050179, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GORDON, Sean (3100 Hanover StreetPalo Alto, California 94304), WANG, Jing (3100 Hanover StreetPalo Al...